ANI Pharmaceuticals Inc (FRA:BSFA)
€ 54 -1.5 (-2.7%) Market Cap: 1.15 Bil Enterprise Value: 1.62 Bil PE Ratio: 0 PB Ratio: 3.00 GF Score: 85/100

ANI Pharmaceuticals Inc at Guggenheim Healthcare Talks Transcript

Feb 08, 2024 / 03:30PM GMT
Release Date Price: €51 (-1.92%)
Vamil Divan
Guggenheim Securities, LLC - Analyst

All right. And I think we're ready to get going here with our next session. And thank everyone again for joining us for the Guggenheim Biotech Conference this year and for day two and next up in this room, we have a and I pharmaceuticals to I'm Vamil Divan by the way, if you don't know me on the pharma and U.S. biopharma analyst here joined up here by nickel. Wondering who's the President and CEO of eOn aaiPharma. Thanks so much for for joining us today, and we're going to do a fireside chat format so I have some questions. I'm going to go through. If anyone in the audience want to ask a question, please raise your hand and we can get your question in a well, but I'm maybe just for people who may be a little bit newer to the story around a farm, obviously been a pretty exciting times last couple couple of years here. And if you just sort of give an overview of the Company, the key sort of business segments that you're focused on. And so the key metrics in terms of recent performance I know you haven't reported Q4 yet, but just at least through the third

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot